If I could just jump in here, I think it's such an important question, but also one that, for the rare diseases community, has become disproportionately difficult. I mention this because you get treatment guidelines for the more major diseases, but at the same time, for instance, we will have a patient who has been waiting for a kidney transplant, but who gets put aside because he's not in the same category as other transplant patients. We have another patient who's waiting for a micro-radiation therapy. Again, it took a lot of advocacy to get her in in the same way as a patient with another cancer has.
We have recommended that there be a parallel task force that would be made up of experts but also include, from our point of view, many of our specialists who are able to put the patients into a proper triage. As we anticipate another wave, I think we really want to do the things you're recommending.
How do we set up the ability to handle these other patients so that we don't end up with a backlog? Our fear is about what happens a lot of times, that the more common and better-known conditions always end up getting prioritized because people don't know the others and don't recognize the risks of those others, so we need to have a task force that can put all of that into perspective.